Sachem Capital Corp. 7.125% Not
Sachem Capital Corp. 7.125% Not (SCCF) Financial Performance & Income Statement Overview
Review Sachem Capital Corp. 7.125% Not (SCCF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Sachem Capital Corp. 7.125% Not (SCCF) Income Statement & Financial Overview
Review Sachem Capital Corp. 7.125% Not SCCF income statement with detailed quarterly and annual figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $10.78M | $11.44M | -$11.21M | $14.79M |
Cost of Revenue | $0.00 | $92000.00 | $479000.00 | $290000.00 |
Gross Profit | $0.00 | $11.44M | $10.07M | $14.49M |
Gross Profit Ratio | $0.00 | $1.00 | -$0.90 | $0.98 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.30M | $1.35M | -$1.26M | $2.30M |
Operating Expenses | $9.71M | $10.41M | $4.51M | $19.32M |
Total Costs & Expenses | $0.00 | $10.41M | $18.46M | $19.61M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $92000.00 | $91000.00 | $0.00 |
EBITDA | $1.07M | $7.09M | -$29.57M | -$4.82M |
EBITDA Ratio | $0.10 | $0.62 | $2.64 | -$0.33 |
Operating Income | $1.07M | $7.00M | -$20.86M | -$4.82M |
Operating Income Ratio | $0.10 | $0.61 | $1.86 | -$0.33 |
Other Income/Expenses (Net) | -$297000.00 | -$1.24M | -$18.48M | -$1.32M |
Income Before Tax | $769000.00 | -$213000.00 | -$39.34M | -$6.15M |
Income Before Tax Ratio | $0.07 | -$0.02 | $3.51 | -$0.42 |
Income Tax Expense | $0.00 | $0.00 | -$43.88M | $0.00 |
Net Income | $769000.00 | -$213000.00 | -$36.13M | -$6.15M |
Net Income Ratio | $0.07 | -$0.02 | $3.22 | -$0.42 |
EPS | $0.02 | -$0.005 | $0.14 | -$0.10 |
Diluted EPS | $0.02 | -$0.005 | $0.14 | -$0.14 |
Weighted Avg Shares Outstanding | $46.88M | $46.78M | $47.41M | $58.89M |
Weighted Avg Shares Outstanding (Diluted) | $46.88M | $44.24M | $47.41M | $44.24M |
Over the last four quarters, Sachem Capital Corp. 7.125% Not achieved steady financial progress, growing revenue from $14.79M in Q3 2024 to $10.78M in Q2 2025. Gross profit stayed firm with margins at N/A in Q2 2025 versus 98% in Q3 2024. Operating income totaled $1.07M in Q2 2025, maintaining a 10% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.07M. Net income rose to $769000.00, with EPS at $0.02. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan